MBX MBX Biosciences: Rasio total nilai perusahaan marang pendapatan

Logo perusahaan publik MBX Biosciences, Inc. (MBX)

The enterprise value-to-annual revenue multiple correlates with the complexity of biomaterial transportation, where 0.00 describes the current status of the metric. MBX Biosciences Inc (MBX) establishes its technological barrier through unique endocrine peptides and patent protection. Simultaneously, the company implements ESG standards in drug production, adhering to bioethics and chemical disposal regulations. This chart helps assess the asset's market value relative to its sales.

Rasio nilai perusahaan marang pendapatan MBX Biosciences Inc (MBX): kanggo periode 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar MBX Biosciences Inc (MBX)

- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:MBX Biosciences Inc MBX
Barang unggulan MBX Corp

This indicator determines the market value of the business, adjusted for net debt, in comparison to generated revenue. By analyzing the EV/Sales multiple, an investor assesses the premium paid for the asset's operating sales. The calculation combines market capitalization and liabilities, eliminating the influence of the financing structure on the final valuation. This chart's dynamics allow for the timely detection of overvalued quotes. For MBX Biosciences Inc (MBX), this is critical when independently developing endocrine drugs without external M&A support.

Analisis pesaing MBX Biosciences Inc

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)